All posts by didiercoeurnelle

One year later: A review of the two Heales-funded studies on the longevity of aged rats

One year later: A review of the two Heales-funded studies on the longevity of aged rats (i.e. January 2022).


Evaluation of the effect of plasma from young rats on the life span of old rats (Rodolfo Goya, Argentina) 

The experiment started on November 22, 2020, all rats were 25 months old. Initially, we had 8 control rats and 9 treated rats, i.e. 17 female rats.

In December 2020: After only 1 month of the experiment, 2 treated rats died (on December 12 and 30). No control rats died but the weight of one of these was decreasing rapidly, indicating that it was likely to die soon. In addition, one of the treated rats had a large mammary tumor. 🡪Total: 8 control rats + 7 treated rats, 26 months old.

In January 2021: 3 control rats died (on January 8, 25 and 29). Notably, one rat that had lost a lot of weight dragged its hind legs and was suffering from myoneural junction degeneration. 🡪Total: 5 controls + 7 treated rats, 27 months old.

In February 2021: Looking at the evolution of the survival curve, we think that the treated rats might live longer, as we had not had any deaths of treated rats for 13 weeks. 🡪Total: 5 control rats + 7 treated rats, 28 months old.

In March 2012: 2 more control rats died, they had lost weight and were weak (March 24 and 31). It now seems more likely that treated rats live longer than untreated ones. 🡪Total: 3 control rats + 7 treated rats, 29 months old.

In April 20021: A control rat died on April 11. The rat was in agony and we found a mammary tumor. Currently, only 25% of control rats survive. The plasma treated rats are doing well so far. So it seems clear that they will outlive the control rats. The question is how long they will survive. 🡪Total: 2 control rats + 7 treated rats, 30 months old.

In May 2021: Another control rat died on May 5, 2021. It was losing weight and had dropped below 200 gr. Two treated rats died (May 3 and 25). One of the two rats had a peri-ocular infection and the infection had penetrated the brain. Currently, only 13% of the control rats survive compared to the 67% of the experimental rats that are still alive. Regarding the results of motor tests, we had not observed any significant difference between the control and treated rats. 🡪Total: 1 control + 5 treated rats, aged 31 months.

In June 2021: The news is not very good. On June 4, another plasma treated rat died. Only 9 days after the last death of a treated rat (May 25). Surprisingly, the rat appeared to be healthy, stable in weight and had no obvious pathology. However, we did find blood in the vagina. We also noticed that another treated rat was losing a lot of weight, so it might die soon… Indeed, this rat died later in the month (June 22). The average lifespan of both groups so far is 29.8 months for the control rats and 32.0 months for the treated rats. The age of 50% survival is 2.2 months higher in the treated rats. Currently, there are 3 experimental (33%) and 1 control that are still alive and appear to be healthy. For the 3 treated rats, 2 are healthy and have no problems, but the 3rd is very lean with a body weight of 175 gr and will probably be next, but when?  🡪Total: 1 control + 3 treated rats, 32 months old.

In July 2021: As predicted, this rat died on July 2. The last control rat is doing reasonably well. 🡪Total: 1 control +2 treated rats, 33 months old.

In August 2021: Another treated rat died on August 3. 🡪Total: 1 control + 1 treated rat, 34 months old.

In September 2021: At the beginning of the month, the treated rat and the control rat were alive. Neither had any obvious pathology. However, the treated rat showed a progressive decline and was not likely to live beyond September. Indeed, the last treated rat died on September 24. The last control appears healthy and will not die soon. Its body weight and appearance remained stable for at least two months. 🡪Total: 1 control + 0 treated rats, 35 months old. 

In October 2021: On October 18, the last control died at the age of 36 months, which is the maximum lifespan of albino rats in the laboratory. 🡪Total: 0 controls + 0 treated rats, 36 months old. End of the experiment! 

The first conclusions are:

  • Regular (fortnightly) treatment of old rats with young plasma temporarily keeps the rats healthier than untreated ones. 
  • As a group, control rats emerge from the plateau portion of the survival curve earlier than treated rats. This represents an approximate 2-month increase in survival for the 50% of treated rats.
  • However, when treated rats leave the plateau region, the mortality rate is as rapid as in controls (comparable slopes).
  • The maximum lifespan was not significantly prolonged by the young plasma treatment. The fact that one control survived all treated rats did not change the statistics of the experiment.
  • When treated rats leave the plateau area, their appearance deteriorates and they look like the surviving control.

What will happen next? We plan to measure epigenetic age in blood samples from control and experimental animals every 15 days during the experiment. We plan to send the blood DNA to Steve Horvath. From the DNA methylation data, we will also analyze what is called the DNA methylation landscape. We first need to organize the blood samples collected over nearly a year and discuss with Dr. Horvath whether we measure them all or select some.


Evaluation of the effect of plasma fraction treatment on life extension in aged female Sprague Dawley rats (Harold Katcher, India) 

The experiment began on January 29, 2021, when all rats were 24 months old.  Initially, we had 8 control rats and 8 treated rats, i.e. 16 female rats.

The objectives of the study are to evaluate the extension of the lifespan of old rats after treatment with plasma fractionation and inflammatory biomarker levels at periodic intervals throughout the life of the animal.

Different parameters will be evaluated: body weight, grip strength, cytokine estimation, TNF-alpha and IL-6 (Interleukin-6) levels. The experimental group will receive a total of four intravenous injections of « Elixir » (E5), 0.7- 1 ml, every 90 days.

February to October 2021: No rats died. They were all in good health. 3 doses of Elixir have already been injected. A first dose in February, a second in April and a third in July. The body weight of the treated rats was 275 gr at the beginning of the experiment and 325 gr after 7 months. Treated rats had a better coat, less fat and more muscle mass. In July, the difference was minimal, not very noticeable. But by September, there was a clear physical difference between the control and treated rats. They were more active and healthier. Grip strength was significantly higher in the treated rats than in the control rats. TNF-Alpha and IL-6 levels were significantly lower in treated rats than in control rats. 🡪Total: 8 controls + 8 treated rats, 24 months to 33 months.

In November 2021: All rats received their 4th dose at the end of October. The first control rat has died. Organs are being conserved to proceed with histopathological examination. 🡪Total: 7 controls + 8 treated, 34 months old.

In December 2021: A second control rat died on December 1ᵉʳ. 🡪Total: 6 controls + 8 treated, 35 months old. 

This experiment is still ongoing at this time. We have to wait and see what happens. For now (i.e. January 2022), all the treated rats are still alive!

Update 2022: 

In February 2022: 1 control rat died (4th February).  A natural death, the animal showed no apparent signs of disease. The animal was very sullen for a week. On 14th February : 1st treated rats died. No signs of tumour or disease were observed in the animal during dissection. The organs of all dead animals in the study are kept for further research. 🡪Total: 5 controls + 7 treated rats, 37 months old.

In April 2022: One additional death in the treated group. 🡪Total: 5 controls + 6 treated rats, 39 months old.

In May 2022: 1st May :  one control rat died. Only in 12 hours, on 5th May, there was 1 death in the control group and 1 death in the treated group. 20th May : one more control and one more treated rat died. Animals showed signs of multiple organ failure on dissection and had no symptoms of any disease. On 23th May, again one more treatment rat died. 🡪Total of the surviving rats: controls + 3 treated, 39 months old

 


Note: In addition to the Yuvan Research communication on the rat experiment, there is also information on a product called NEEL Gel. Heales vzw/asbl is not involved in the impact of E5 on humans.

Heales Monthly Letter. The Death of Death. N° 153. December 2021. If humans didn’t die of old age, would we regret it?

Imagine a rather educated mouse asking himself if it is theoretically possible to live more than two and a half years his average life expectancy? Of course, it is possible, she would say, look at the human species (…), mammals like us that live thirty to forty times longer! Beyond our biological limits: The secrets of longevity. 2011. Miroslav Radman.


Theme of the month: If humans didn’t die of old age, would we regret it?



Introduction
Let’s imagine a world not so different from ours. However, humans and most animals would not experience aging.

In this world, would we wish senescence, that is, the progressive degradation until death, on ourselves and our children?

Let’s imagine, for example, a biological environment a little more « Lamarckian » than the one we live in. In epigenetic evolutions, acquired characteristics would be more transmissible. An older animal would have, as here, advantages in terms of experience. Moreover, the descendants would benefit from an increased transmission of acquired characteristics. In this case, natural selection would have less « need » for senescence, since the evolution of species could occur because of changes during the life of individuals. Let us imagine that the probability of dying of natural causes is therefore relatively stable, from one year to the next, once the adult age is reached. Let’s imagine a planet with no aging death (and also no aging degradation) for most living species.

For the rest, the « laws of nature » would apply: selection of the most adapted, evolution of preys, predators and parasites, competition and cooperation between animals, plants, bacteria, fungi… Animals would live longer, without aging, but would still die from all other causes. Biological immortality is not the same as immortality.

A world without aging would not be paradisaical but…
Obviously, it is impossible to imagine all the consequences. Let’s focus on humans. Theoretically, some could live for thousands of years. But this would be extremely rare before the development of civilizations because epidemics, predation, violence would strike all individuals.

But once civilizations appeared, the environment would be radically different. The accumulation of knowledge would be faster, philosophers, scientists, leaders could be influential for centuries. Religions would exist, but they would logically be more peaceful, less focused on the afterlife, more concerned with bodies and souls here than with the afterlife.

Soon enough, in the more prosperous regions, birth control would expand. Soon enough, science and medicine could focus more on preventable causes of death. Indeed, the positive stakes of disease control would be higher, there would be more years of life to gain.

As for these humans, the capacities would not decrease with age, the mechanisms of nostalgia, of withdrawal to the past, would be less. Indeed, nostalgia is often the regret of youth following the loss of energy, health, taste, other senses… Nostalgia following the loss of loved ones would also diminish. 

In our contemporary world, philosophy is sometimes defined as « learning to die » (and to die quickly). Where death would no longer be inevitable, at least on the scale of centuries, philosophy would be more about learning to live, learning to respect others and oneself. In a more stable world, the need for an environmental balance is more obvious.

Advancing age would be, as in our world, synonymous with wisdom. It would be a wisdom with less bitterness and regret of the past and therefore more openness to the future.

In this place where death is no longer inevitable and is becoming rare thanks to technological and medical progress, it is possible to imagine that any death inflicted, any murder, would not only be unacceptable, it would become unimaginable. Just as today killing a child is almost unimaginable, because he has « his whole life ahead of him », whereas in the past infanticide was often tolerated and sometimes totally accepted, especially because many children died in infancy.

In a world without age-related degradation, would we invent aging?
Some philosophers, some religious leaders might want the older ones to disappear. Some might say that it is necessary to renew the population, to have children without the risk of overpopulation.

Would the representatives of this current of thought want to kill the most advanced people in age? And if so, create a system where death is slow, insidious, progressive, painful, ineluctable… rather than, for example, creating compulsory euthanasia for some?

This seems unlikely in a world of less violence. Already today, even the most bloodthirsty regimes no longer (almost?) officially practice torture as a means of pressure. So inflicting aging and then death …

What if the glass was half full?
Let’s finally imagine an environment where humans are not amortal, but live twice as long once they are adults. The prime of life would be at 100 years and Jeanne Calment would have lived 245 years.

No one would likely propose ending life after 80 or 90. It is the situation well beyond that which would be « normal » and would appear to almost everyone as desirable… until the situation changes.

Just as no one today proposes to end life at age 50, when that was the « normal » maximum lifespan for most of human history.

Conclusion
If aging did not exist, we would not have to invent it. All other things being equal, we probably wouldn’t consider it, even for our worst enemy. We would not wish for years and sometimes decades of unbearable degradation ending in death.

Moreover, if we lived in a world without aging, not only human life, but also the lives of sentient beings (capable of suffering) would be far more precious. Even the most disrespectful of individuals, raised in this universe, would have difficulty imagining inflicting the torments of an endless torture called aging. Just as today, even a violent recidivist thief would probably not think of burning the feet of an elderly person to make him confess where his money is, and then murdering him, a common practice in France and elsewhere until the early 19ᵉ century.

Aging is now inevitable. We have already managed to humanize it considerably. We are also managing to slow it down a bit. Tomorrow we may be able to stop it. In all likelihood, we will not regret it any more than we regret the eradication of the plague and cholera.


Good news of the month


  • Japanese scientists develop a vaccine to eliminate cells responsible for aging. The team, including Toru Minamino, a professor at Juntendo University, confirmed that mice given the vaccine had a decrease in the number of zombie cells, known medically as senescent cells. The team identified a protein found in senescent cells in humans and mice and created a peptide vaccine based on an amino acid that constitutes the protein. This news has received significant media coverage. It is part of the many hopes for senolytic products. However, the experiment concerns only mice. Moreover, the maximum life expectancy was verified on « progeroid » mice (with a much shorter life span), but not on « normal » mice.
  • The first clinical trial of a nasal vaccine for Alzheimer’s disease began in Boston. The vaccine, formulated from an immune-boosting substance (Protollin), is intended to prevent and slow the progression of Alzheimer’s disease, the disease associated with aging for which medical research has been slowest… A Phase 1 trial involves 16 participants, aged 60 to 85, all with early-stage Alzheimer’s disease but in good general health. They will receive two doses of the vaccine. The research team will measure the effect of nasal Protollin on the immune response, particularly its effect on white blood cells, by examining cell surface markers, genetic profiles and functional tests.

For more information:

Recent developments in gene therapies for longevity. Heales Monthly Letter The Death of Death. November 2021.

John Harris, former editor of the Journal of Medical Ethics, argues that as long as life is worth living, according to the individual, we have a powerful moral imperative to save life and therefore to develop and offer life-prolonging therapies to those who want them (Source). 


Theme of the month: Recent developments in gene therapies for longevity


Introduction 

The average lifespan of both animals and humans varies according to many factors. For animals,  diet, predation, disease and  climatic conditions play the most important roles. In humans, lifestyle, disease and social conditions are the determining factors.

But when it comes to the maximum lifespan of animals, like that of humans, the most important element is the genetic heritage. 

We still know very little about the genetic differences that favour or hinder longevity in humans. Studies of genetic characteristics related to longevity have been conducted, including studies of supercentenarians.  Although genes such as the klotho gene are sometimes cited, no single gene or group of genes appears to have a very strong positive influence.

A human being who lives in a perfect environment with adequate health care and an exemplary lifestyle would never live past the age of 122. It should be noted that the oldest person in the world has been a woman for almost 40 years, which can be explained by the genetic difference between men and women. 

Place a mouse in a mouse paradise. No matter what happens, it won’t live past five years. Place a Galapagos tortoise in a chelonian paradise and it will live at most two centuries.

Very similar animals can have very different maximum life spans. For example, the Labord’s chameleon of Madagascar is the terrestrial vertebrate with the shortest life span. It lives only 4 or 5 months. While its distant cousin from the same big island, Parson’s Chameleon, can live for about ten years.

In other words, we know that few genetic modifications can allow considerable changes in lifespan.

This is one of the reasons why gene therapies are among the most promising therapies for longevity.

What is gene therapy? 

Gene therapy is one of the preferred ways to treat genetic diseases, but also certain cancers. It consists of inserting into the patient’s cells a normal version of a gene that does not work and causes the disease. 

The functional gene then allows the patient to produce again the protein whose deficiency was the source of the disease.

However, three conditions must be met: 

  • Knowing the gene responsible for the disease, i.e. the function of that gene, so that the cell can be « repaired ».
  • Allowing the gene to reach and enter the cell with the help of a « vector », most often a virus that has been rendered harmless to the patient.
  • And associate the gene with a « promoter », a small DNA sequence that allows it to function once inside the cell.

It is also possible to transform the genetic heritage of subsequent generations. It is conceivable that one day our children could live longer and healthier lives as a result of genetic modification. This raises innumerable ethical questions, some of which have been addressed by the birth of two (or perhaps three) genetically modified babies in China. These issues will not be discussed here.

The gene therapy revolution

In 2000, for the first time in the world, gene therapy demonstrated its effectiveness with bubble babies, children with severe immune deficiency who returned to normal life with the treatment. However, the therapies were slowed down and then virtually halted for more than a decade following the deaths of two patients, including Jesse Gelsinger. However, during this interruption countless lives could have been saved.

Between 2015 and 2020, gene therapy has experienced a considerable boom. Several clinical trials have been conducted to treat certain blood, skin and neuromuscular diseases. Some of these trials have been sufficiently successful to lead to market authorization in the United States and Europe. 

In 2017, a team of European doctors managed to replace 80% of a little boy’s epidermis (suffering from epidermolysis bullosa) with gene therapy.

By 2019, about ten gene therapy treatments for rare blood, vision, muscle and certain cancers had received marketing approval in the United States or Europe.

In the same year, the first gene therapy drug (Zolgensma) capable of saving the lives of babies with diseases such as spinal muscular atrophy was put on the US market. 

Other treatments for Pompe disease, adenosine deaminase deficiency, beta-thalassemia, acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and Leber’s amaurosis have been developed.

However, treatments are still usually aimed at uncommon diseases, generally linked to an « error » in a single gene.

Gene therapy and longevity: Can it delay or reverse age-related diseases including neurodegenerative diseases?

In 2019, a study by George Church and his teams showed favorable results of a therapy acting simultaneously on three genes in mice with various age-related symptoms.

In the same year, an experiment on a gene for telomeres was carried out by researchers from the Chinese Academy of Sciences on mice in 2019. This resulted in a longer life expectancy.

In 2020, mRNA vaccines were used to induce immunity against COVID-19. This method is similar to gene therapy. However, the changes concern the RNA and not the DNA. 

In October 2021, BioViva, a biotechnology startup led by E. Parrish, demonstrated that by administering gene therapy to six patients with dementia that a reversal of dementia symptoms such as cognitive impairment could be observed. 

The American Elizabeth Parrish is also the first known case of self-testing of a gene therapy targeting ageing processes. The treatment consists of injections of adenovirus, which could extend leukocyte telomeres and thus strengthen muscle mass.

Conclusion

A massive sharing of knowledge, including statistics, about genetic endowments is developing. Investments for a longer healthy life seem to accelerate and improve. The European Union is proposing legislative tools for « altruistic » databases. 

Billions of sequencings (total or partial) have been performed on animals, plants and humans. The pooling of these data and their analysis, in particular by means of tools based on artificial intelligence, is continuing. Thanks to genetic modification technologies such as CRISPR, it should be possible to break through the « glass ceiling » of the maximum lifespan for mice and then for humans in the near future.


The good news of the month


The European Longevity Initiative was launched by a non-governmental organization with members in some 20 EU countries.

Its proposal was the most supported of the Conference on the Future of Europe and is still one of the most supported.

The main promoter of the idea is the Hungarian scientist Attila Csordas, who said:  » The only real solution (for many, many diseases) is to start treating the root causes of biological aging (…). We have experimental strategies to slow down the rate of accelerated aging and reduce morbidity and mortality in late life. To achieve this in the European Union, we would like to propose effective legal, budgetary, regulatory and institutional commitments to enable science-intensive healthy longevity research and technologies, large-scale geroprotective clinical trials focused on ageing and equitable access to these technologies to increase healthy life expectancy in the European Union.”  

The European Health Data Space is at the centre of many projects aimed at better exchange of health data for medical and research purposes. An international conference on 19 November on « Innovations in Consumer Longevity Data » is one example. 


For more information:

Newsletter. The Death of Death. October 2021. The Terror Management Theory.

We have long since (…) touched Mars, the Moon, harnessed nuclear power, artificially reproduced DNA, and now have the biochemical means to control births; why should death itself, « the last enemy », be considered sacred and beyond conquest? Alan Harrington, novelist, 1977 (The immortalist). 


Theme of the month: The Terror Management Theory 


Introduction

Terror Management Theory (TMT) was developed in the 1980s by Jeff Greenberg, Tom Pyszczynski and Sheldon Solomon. 

According to these authors, all human beings are confronted with two realities.

On the one hand, humans, like all animals, have an instinct to protect themselves and to try to survive. On the other hand, they have a higher level of self-awareness that allows them to understand, unlike other animals, that they are alive and that they will eventually die.

It undeniably involves the frustration of the desire to stay alive. This is both frightening and motivating, and represents a central and unique psychological conflict in human beings.

But this theory, already discussed in a letter The Death of Death from May 2010, also teaches us that man, in order to face the fear of death, has developed defense mechanisms. Knowing that we are not going to survive as individuals, we identify ourselves with the collective, our survival goals become collective goals. In a global vision, we could say that all forms of art, culture, tradition, long-term collective construction participate in this mechanism. It is a matter of valuing the culture of belonging that allows us to strengthen our self-esteem in the conviction that as individuals we contribute to building this sense.

Unfortunately, this mechanism also has negative aspects. By reinforcing group values, it encourages the rejection of those who are different. Here, as in other areas, fear is a bad counsellor, a counsellor of withdrawal not into oneself, but into one’s group.

How has Covid-19 influenced our reaction to death?

The coronavirus pandemic has reminded us how vulnerable we are, especially as we age. A fact we put out of our minds when times are less threatening.

Across the world, we have seen solidarity, but also withdrawal: some have mobilized to help others (e.g. making protective gear for caregivers or organizing fundraisers), others have stockpiled cans and toilet paper.

Some recent studies show that the perception of threat (Covid-19) is related to government decisions such as lockdowns (if the government orders lockdowns, the disease must be very serious) and to the number of reported cases. The increase in the number of cases in some countries would be correlated with the increase in conservatism and authoritarianism.

Only humans are affected

As already written, awareness of inevitability of the death is unique to humans. It is possible that some animals are aware of the death of their fellow creatures and the risk to themselves. Moreover, this awareness does not even concern all humans. Young children usually live a life that seems limitless to them with joy and without boredom.

Could it be human nature to learn how to die…

Neither the sun nor death can be looked at steadily, wrote La Rochefoucauld. To philosophize is to learn to die, as Socrates and Montaigne have said. No conscious adult human being is indifferent to the inevitability of his end. Faced with the passing of time, we feel, as on the edge of a precipice, fear, but also fascination. No civilization deals with the death of our fellow human beings without a specific approach.

Or could it be the nature of man to always struggle to overcome death?

Almost all civilizations, almost all religions, explain that death is not the end of the journey.  From an agnostic perspective, the main reason for beliefs in the afterlife is of course to deal with the fear of dying.  The search for immortality is found in beliefs, practices and rituals. Sometimes these are affirmations, incantations.  Sometimes they are methods that could be called « pre-scientific », instructions for avoiding death or for making death only a temporary phenomenon. 

For the Taoists, it was a matter of learning to live according to very ascetic methods. In ancient Egypt and Christianity as it was taught until recently, it was a matter of preserving the body, by embalming or burial to allow for the return, the reincarnation (return to the flesh). The Catholic Church refused cremation until recently.

An unconscious mechanism 

This is a fundamental aspect of managing terror. Our defences are constituted by what Ernest Becker called « The Denial of Death« . Faced with what is both unbearable and inevitable, we develop unconscious processes. If these processes were conscious, they would lose much of their effectiveness.

What about tomorrow, in a world where amortality becomes conceivable?

Living without unbearable fear is, of course, a desirable mechanism. But it can also be an obstacle to the struggle for healthy longevity, when unconscious mechanisms lead us not to fight against, or even to « love » death (from old age).

Collective ideals are the result of feelings of belonging to groups that were initially opposed to each other. Today, they allow us to behave in an increasingly global community to live in a more peaceful, more united and more sustainable way, especially in the fight against global warming. In the same way, tomorrow, a better « management of the fear of death » could allow us to make better progress towards a much longer healthy life, even one day without time limits.


Good news of the month


  • Although this is a fragile development, mortality from the Covid-19 epidemic is slowing down. While the number of people affected continues to rise, the number of deaths both in Belgium and worldwide is decreasing, showing the increasing effectiveness of preventive vaccines and therapeutic treatments.
  • Among the most promising treatments for the coronavirus, molnupiravir is providing renewed hope: the tablet is believed to halve the risk of hospitalization or death in Covid-19.

For more information:

Newsletter. The dead of the dead. N° 150 September 2021. Microbiome and longevity

« But there is every reason to believe that adding Triphala and these probiotics to the diet is a guarantee of longevity and health. »

Satya Prakash (Biomedicine and Cellular Therapy Research Laboratory, Department of Biomedical Engineering, McGill University, Canada) (note: this is only about moderate improvements in healthy life span with better nutrition). 


Theme of the month: Microbiome and healthy longevity


Introduction 

Our body is made up of complex, fascinating, interdependent and changing systems.

All of them vary throughout the ages of life and, unfortunately, gradually deteriorate. 

The digestive system is the one that most directly confronts the outside world, the most changing, hostile and dangerous environment.

Every year, nearly a ton of food and drink, but also kilos of medicines, non-nutritive substances and millions of billions of bacteria, viruses and parasites pass through it and sometimes settle in it. As humans are omnivores, the diversity is particularly great. This is one of the reasons why research approaches to longevity are also diverse.

The importance of the gut microbiota

Our body is home to many different bacterial species. These communities of microorganisms, called « microbiota« , take up residence in different parts of our body: the mouth, the skin, the vagina… But above all the intestine! This organ, which is about 8 meters long, is home to up to 100,000 billion bacteria, mainly located in the small intestine and the colon. Scientists estimate that nearly 90% of fecal matter is made up of bacteria!

These bacteria, associated with other microorganisms such as viruses and yeasts, form the intestinal flora, now renamed « gut microbiota » by the scientific community.

In utero, the fetal digestive tract remains a sterile environment. During birth, breastfeeding and dietary diversification, the intestinal microbiota of an individual builds up over the years, until it contains nearly 1,000 different bacterial species in a healthy adult. A bacterial world that weighs nearly 2 kilos.

The 200 million neurons of the digestive tract

The same neurons as those in our brain line our digestive tract, some people call it a « second brain« ! 

The primary function of the enteric nervous system is to ensure the motor function of the intestine. The nerve cells are also responsible for transmitting information from our intestine to our brain. In addition, like the brain, the neurons of the intestine are able to produce hormones and neurotransmitters. 

Our emotions are also lodged in our intestines. Being « scared to death » or « having a knot in your stomach », « digesting information » are expressions that illustrate realities.

Links between Alzheimer’s disease and the microbiome have been established by studies. On the other hand, it does not seem that the neurons of the « second brain » suffer from a specific Alzheimer’s or neurodegenerative disease, even if the nervous control degrades with age (one of the causes of incontinence in the elderly).  

Could the microbiota and the gut be the key to improving longevity?

Recently, variations in the gut microbiota have been associated with age-related phenotypes and probiotics have shown promise in managing the progression of chronic disease. 

In a scientific paper published in Nature in May 2018, researchers highlight a longevity extension in Drosophila. By adding a combination of probiotics and a plant-based supplement to the diet of Drosophila flies, scientists at McGill University were able to extend their lifespan by 60% and protect them from chronic diseases usually associated with aging.

In this study, novel probiotic and symbiotic formulations were shown, in combination, to extend longevity in male Drosophila melanogaster through gut-brain communication mechanisms with implications for chronic disease management.

Longevity in mice

Researchers discover the potential of microbes to slow brain aging

Research from the APC Microbiome Ireland (APC) SFI Research Centre at University College Cork (UCC) published in Nature Aging presents a new approach to slowing aspects of age-related brain and cognitive deterioration via gut microbes. This research opens up potentially new therapeutic avenues in the form of microbial interventions to slow brain aging and associated cognitive problems.

There is a growing appreciation of the importance of microbes in the gut to all aspects of physiology and medicine. In a very recent study in mice, the authors show that by transplanting microbes from young animals into older animals, they could rejuvenate aspects of brain and immune function.

The researchers explained in the journal Nature Aging, « The gut microbiota is increasingly recognized as an important regulator of host immunity and brain health. The aging process leads to dramatic alterations in microbiota, which are linked to poorer health and frailty in older populations. Transplantation of microbiota from young donors reversed age-associated differences in peripheral and brain immunity, as well as the hippocampal metabolome and aging transcriptome of recipient mice. »

Longevity in humans

A recent study by the Institute for Systems Biology (ISB) shows that depending on the type of intestinal microbiota (the composition of the microbial flora that permanently inhabits our intestines), we age in better or worse health. This would therefore have an impact on longevity.

The microbiota changes after age 50

The researchers analyzed the gut microbiota and health status of more than 9,000 people aged 18 to 101, with a particular focus on the 78+ age group. In the latter group, they found that the microbiota changes in composition as we age and becomes more and more « unique » but that the different microbiota of healthy people all perform similar metabolic functions.

Our bacteria produce anti-aging substances

In correlation, higher concentrations of certain metabolites produced by the microbes in the intestines were measured in the subjects’ blood. Thus, it seems that changes in intestinal flora in healthy aging are linked to the production of certain metabolites whose effect on longevity is known, such as indole for example.

It is known that certain types of intestinal bacteria convert tryptophan (an essential amino acid) into indole, which passes into the bloodstream. It has been shown that indole prolongs life in mice and reduces intestinal inflammatory processes.

Another microbial metabolite, phenylacetyl glutamine, is found in large quantities in the blood of centenarians.

To conclude, it is noted that the microbial flora, continuing to evolve at an advanced age, would make it possible to better preserve health and to improve longevity, it is in relation to the common production of certain metabolites (like the 2 examples quoted previously). These modifications would be done especially after the fifty years.

Changes in microbiota with age

While the composition of our microbiota remains relatively stable during adulthood, changes in diet, even medication (antibiotics, anti-acids, …), the slowing down of gastrointestinal transit and digestion … lead to an imbalance of the digestive flora as we age

The diversity of bacterial species tends to decrease with age. Among other things, there is an increase in enterobacteriaceae and germs that can then become pathogenic by their number, such as streptococci, staphylococci, etc. These develop more easily in an inflammatory environment, and will themselves maintain a localized inflammation, as well as a too great permeability of the intestinal mucous membrane.

It has been observed in people over 105 years old, an increased presence of certain bacterial families (akkermansia, bifidobacteria and christensenellaceae). This suggests that this presence appears to favor the control of inflammation and a better maintenance of immunity, in spite of repeated stress and the constant work of defense of a whole life, against foreign microbial elements.

For example, bifidobacteria represent nearly 90% of the bacteria of breast-fed infants, and only 5% at the end of life. Their contribution seems beneficial in several ways in the elderly, according to studies.

It would be possible to define a person’s age by studying the composition of their microbiota 

Longevity researcher Alex Zhavoronkov and his colleagues from artificial intelligence startup InSilico Medicine analyzed the DNA of the gut microbiota of healthy people from different countries. A total of 1165 people between the ages of 20 and 90 were enrolled in the study and more than 3600 stool samples were collected to study the gut microbiota data and enable the tool to be trained.  The machine was able to give the age of the individuals with a margin of error of only 4 years!

Moreover, of the 95 bacterial species studied, 39 of them could predict age. The researchers were also able to show that certain species of bacteria were more abundant as we aged, such as Eubacterium hallii, which is associated with a healthy balance of intestinal metabolism; and others, on the contrary, were in smaller quantities, such as Bacteroides vulgatus, which is correlated with ulcerative colitis.

What about tomorrow?

So far, very different diets (without excess) and microbiota lead to relatively similar maximum lifespans. A Japanese and a French person have a very different diet, but a similar longevity.

However, further research, particularly the analysis of genetic data from the countless organisms that populate our digestive organs, opens up significant prospects for longevity. Among the leads, those influencing the nervous system are among the most important. 


September News


Aubrey de Grey, the world’s best known biogerontologist, helped the SENS organization raise $28 million. Immediately afterwards, on the basis of harassment charges, he was expelled from SENS, among others. However, at the time of writing, none of the thousands of women and men, minors or adults, who have been in public or private contact with him for decades have, to our knowledge, taken legal action. Whatever the

media’s temptation and the pressure to condemn without procedure, and while respecting the rights and opinions of everyone, including the alleged victims, we will stick to fundamental human rights: Everyone accused of a criminal act is presumed innocent until proven guilty in a public trial in which he or she has been given all the guarantees necessary for his or her defense.

American billionaire and philanthropist Yuri Milner has announced the creation of Altos Labs, a company that aims to make radical advances in human longevity with funding in the hundreds of millions of dollars. Jeff Bezos is also widely quoted as a co-founder. Renowned scientists specializing in aging research have been recruited or associated, including epigenetic clock specialist Steve Horvath, Nobel laureate Shinya Yamanaka and Spanish rejuvenation researchers Juan Carlos Izpisúa Belmonte and Manuel Serrano


 For more information:

Heales Monthly Letter The Death of Death N° 149. August 2021. Longevity and altruism

« And so, if for millennia the task of common men and daydreaming philosophers alike had been to ask, “What happens if we die?”. Today we’re tasked with a goal far more challenging: that of examining what happens if we live. […] What if, for the first time in history, we’re building a civilization that relies not on death, but on the deployment of ethical technologies, for its enhancement? » Raiany Romanni, bioethics researcher, Harvard Medical School. Source.


Theme of the month: Longevity and Altruism  


Introduction

The importance of wanting the good of others, for the sake of others (and not for any religious reason or moral obligation) is a concept that is far more important today than it was yesterday. The word altruism itself is less than two centuries old. It was created by Auguste Comte, as an antonym of the word egoism, in 1850. In this letter, we will not address philosophical questions about the deep reasons for altruism. What is important in this letter is that conscious solidarity is one of the reasons for the enormous social progress and longevity. Thus, never in the history of humanity have we been more concerned about others, starting with the elderly and therefore the weakest, than during the current Covid epidemic.

Altruism in animals

Altruism does not only refer to the conscious mobilization of humans for others. In biology, altruism refers to the behavior of an individual that increases the selective value of another individual while decreasing its own abilities. Altruistic behaviors in biology appear most obviously in kinship relationships, such as kin selection. They can also be observed in larger social groups, such as in social insects.

They allow an individual to increase the transmission success of his or her genes by helping related individuals who share those same genes.

Obligate altruism is the permanent loss of direct  fitness (reproductive) (with the potential for indirect gain). For example, worker bees may forage for food for the colony (individual cost, but collective gain).

Optional altruism is a temporary loss of direct capacity (with a potential indirect gain from personal reproduction). For example, a Florida scrub jay may help at the nest, then gain parental territory.

Examples:

  • Wolves and wild dogs provide meat to pack members not present at the kill. 
  • Mongooses support old, sick or injured animals.
  • Meerkats often have a guard to warn of predator attacks while others are feeding.
  • Male baboons threaten predators and cover the rear while the herd retreats.
  • Bonobos have been observed helping other injured or disabled bonobos.
  • Vampire bats usually regurgitate blood to share with unlucky or sick roosting companions who have been unable to find a meal, often forming a « buddy system. »
  • Lemurs of all ages and both sexes will care for infants that are not related to them.
  • Dolphins support sick or injured animals, swimming under them for hours and pushing them to the surface so they can breathe.
  • In many bird species, a breeding pair receives support in raising their young from other « helper » birds, including help in feeding their chicks. Some will even go so far as to protect the young of an unrelated bird from predators.

Being altruistic may be good for your health!

What if helping others was not just an altruistic gesture? A study published in 2006 in Evolution and Human Behavior suggests that helping children, grandchildren, or more distant relatives may give a boost to longevity.

Scientists at the University of Basel in Switzerland studied 500 people aged 73 to 103. They found that those who cared for their grandchildren lived longer than those who did not: half of the caregivers were still alive 10 years after the study began, while half of the less devoted grandparents died within five years.

In the absence of grandchildren, direct assistance to children, such as housework, has the same effect on longevity. Prosocial behavior by grandparents towards children and grandchildren appears to set an example of altruism for future generations and inscribe this model in their nervous and hormonal systems.

Be careful, however, it is also possible that the differences can be explained by the fact that only healthy grandparents can take care of their grandchildren, because people in poor health have fewer children and therefore fewer grandchildren, less contact, fewer activities…

According to American researchers, the feeling of well-being acts on our genes and boosts our immune system. But happiness is differentiated into two different types and only altruism seems to be able to influence the human epigenome.

 The immune system of altruistic people is found to be more developed than that of people experiencing hedonic well-being (i.e., cultivating one’s own emotions in order to feel happy), researchers reveal in their study published by the scientific journal Proceedings of the National Academy of Sciences (Pnas)

Specifically, after taking blood samples from 80 healthy volunteers, the researchers observed that the human genome seems to respond to a positive psychological state. In case of altruism, inflammatory genes decrease and antiviral genes increase, in order to protect the body.

Effective Altruism

The phrase « It’s the thought that counts » sounds nice, but it is actually morally untenable. Our altruistic actions must be measured by their effectiveness. Effective altruists advocate that we should estimate the « cost-benefit » of our actions to others. For example, providing food worth a certain amount of money may be less altruistic than investing the same amount in better agricultural production by farmers.

In the health field, funding care and medication to reduce the effects of age-related diseases is a useful act, but less so than funding research to end these diseases.

Of course, the outcome of these investments is not certain and the benefit is longer term. Most often, effective altruists invest in projects that are relatively easy to measure and therefore not in wide-ranging efforts such as research. Yet, the benefits of wide-ranging advances are considerable. One euro for care in a nursing home will benefit a few people. One euro for a therapy for a healthy life can benefit all.

The duty of altruism

Helping your fellow man in certain circumstances is a duty for most philosophical and religious currents. It is also a legal obligation whenever a person is in danger in some countries such as France or Germany. This is called the duty to rescue.

 There have been cases where people have been prosecuted for this type of crime because they did not act correctly in view of scientific progress. If the demand and social pressure became strong enough, we could likewise consider it a crime not to invest in research for healthy longevity. The State, at least, could be legally, even constitutionally, ordered to make these investments (in the same way that it is today ordered to guarantee the health of its citizens).

 Note that the fact that the outcome of the assistance is uncertain does not absolve the duty. A person who refuses to help an injured person cannot justify himself by saying that he would probably have died anyway. Therefore, the fact that the outcome of the search is uncertain does not mean that there is no duty.

 In France and Belgium, case law generally considers that only the effect requiring immediate action should be considered. But this could change.

Long-term altruism

Many citizens, especially environmentalists, rightly insist on concern for future generations. In fact, it is also about current generations, because climate change and pollution will already have impacts in our lifetime. They even have some today. But the concern, the altruism for the future, is also to offer a healthier and much longer life to the children who will be born tomorrow.

Finally, we could say that there is even a form of altruism towards this other person who is oneself in the long term. Many of our behaviors are a choice between short-term interest (« bad » eating, smoking, distraction…) and long-term interest (exercise, study…). The choice to work for a longer and healthier life is in my opinion an altruism for one’s future self.


Good news of the month. Potentialities of gene therapies.


It is the genetic heritage that determines quite precisely the maximum lifespan of a human, any other mammal and most animals. The potential of gene therapies for longevity is expanding and becoming clearer. Renowned scientist George Church gave an interview on this topic for the organization Lifespan.io.

 


For more information

See: 

The death of death N° 148. July 2021. Biomarkers and longevity

« Deep biomarkers of aging developed from various types of aging data are rapidly advancing the longevity biotechnology industry. The use of biomarkers of aging to improve human health, prevent age-related diseases, and extend healthy life spans is now being facilitated by rapidly increasing data acquisition capacity and recent advances in AI. They offer great potential to change not only aging research, but healthcare in general, » said Polina Mamoshina, a scientist at Insilico Medicine.

Theme of the month: Biomarkers and longevity

A biomarker is a measurable biological characteristic related to a normal or abnormal process.

In the medical field, a biomarker can be any measurable biological indicator. They can be quantitative or qualitative. Qualitative biomarkers could be involved in detecting a disease process in a yes/no analysis, while quantitative biomarkers are involved in detecting a disease process with a threshold effect. Most diagnoses are based on biomarkers.

Biomarkers and aging

Biomarkers are of growing interest, as they allow the measurement of aging, not on a one-off basis (as is the case with biological age), but on a continuous basis, resulting in a new measure: the rate of aging. Researchers have summarized the biomarkers of aging into different subcategories:

Biomarkers known as »genetic criteria »

The appearance of somatic DNA mutations during aging suggests that the measurement of genomic instability (the loss of the ability to repair DNA during cell divisions) could be a biomarker of aging.

With regard to telomere length, this is decreased with aging. Telomere shortening is explained by a decrease in telomerase activity. The measurement of telomerase enzymatic activity in human cells could be informative to assess aging.

Cellular senescence, the « pausing » of certain cells in response to cellular damage, is a protective mechanism that is increasingly used throughout the aging process. The measurement of cellular senescence is reliable and informative for assessing biological aging.

The increase in the number of epigenetic modifications such as DNA methylation, histone modification, the presence of non-coding RNA, appear during aging. These measurements, known as « epigenetic clocks » have been studied in particular by Steve Horvath.

Repair of cellular damage (damaged macromolecules, organelles) is a key process in maintaining cellular integrity and function. Autophagy capacity decreases with age, resulting in the accumulation of non-functional damaged proteins. Assessing the mechanisms of repair, recycling, and removal of damaged macromolecules could be a measure of biological aging.

Mitochondrial dysfunction, i.e. a weakening of the energy production mechanisms in our cells and of the capacity to manage oxidative stress by the mitochondria, are other interesting markers.

Finally, the evaluation of stem cell depletion, of nutrient sensing dysfunction, and alteration of intercellular communication could also be useful biomarkers to evaluate the aging of an individual.

Biomarkers known as « biological criteria

Abnormal levels of these « markers » indicate an accentuated aging of the organism, and they are, for the most part, linked to a shorter lifespan and a higher risk of disease.

With an anti-aging evaluation, it is possible to evaluate the stage of aging. These biomarkers are classified according to the functions most often altered in aging:

Glycemia and insulin resistance

Aging is associated with a disturbance in glucose metabolism. Disturbances in the regulation of blood sugar levels and insulin spikes are often present in aging-related phenomena.

Biomarkers such as glycated hemoglobin (HbA1c), fasting insulin level and the HOMA index (= insulin*glucose / 22.5)… are indicators reflecting the general state of glycation of tissues, a major phenomenon of aging.

Adiponectin: this recently discovered hormone is correlated with the mechanisms of inflammation. Studies have shown that it steadily decreases with advancing age and has strong links with the onset of metabolic syndrome, diabetes, atherosclerosis and non-alcoholic fatty liver disease.

– Vitamins and minerals

Vitamin D: A study of 10 different populations showed that relatively high levels of vitamin D were associated with a decreased risk of all-cause mortality. Diseases related to aging and vitamin D include osteoporosis and Alzheimer’s.

Vitamin B12: Vitamin B12 levels often decline after age 50. Low levels are correlated in various studies to a higher risk of cognitive dysfunction, dementia and coronary artery disease.

Calcium: it has been shown that advancing age is often linked to a calcium deficit (leading to osteoporosis, among other things). This deficiency is thought to be due to vitamin D deficiency and also to a decrease in intestinal calcium absorption.

Zinc: Zinc deficiency is common in the elderly, due to dietary deficiencies and/or poorer intestinal absorption. It leads to phenomena similar to those observed with the oxidative inflammation of age and immunosenescence (degradation of defenses).

Selenium: A high blood level of selenium is generally correlated in studies with decreases in cancer risk.

Albumin: best known as a biological marker of protein-energy malnutrition, it is also a marker of aging that tends to decrease with age.

Creatinine and urea: they allow the evaluation of a weakening of the renal function.

Chronic inflammation, which generally increases with age, is the best-studied field in immunosenescence. Elevated plasma levels of leukocytes, interleukin 6 (IL-6), and TNF-α (tumor necrosis factor) correlate with loss of grip strength.

Ultra-sensitive C-reactive protein (CRP): this marker of inflammation is correlated with lifespan according to a study of 90,000 people. Lower levels of CRP are associated with greater longevity.

– Hormones

Testosterone: Testosterone levels decline steadily with age.

IGf-1 (insulin-like growth factor 1): the marker for growth hormone. Its decline is associated with aging, called « somatopause ».

Sex Hormone-Binding Globulin (SHBG): as we age, SHBG levels increase by about 1% per year. The decrease in androgens and the excess of estrogens increase the production of SHBG by the liver.

Cortisol: The level of cortisol, the stress hormone produced by the adrenal glands, is correlated with age-related diseases. The more abnormal its secretion, the more glucose metabolism is disturbed.

Dehydroepiandrosterone (DHEA): DHEA sulfate is well known to decrease in blood levels with age in both sexes from the age of 30. One study reported an average decrease of 5.2% per year.

Pregnenolone: generally decreases with age, especially between the ages of 35 and 50 where its level frequently drops by 60% or more. Pregnenolone allows better resistance to stress and is very much involved in cognitive functions and memory.

– Lipids and fatty acids

Disturbances in blood lipids are among the most reliable markers of cardiovascular risk and mortality. Triglycerides and cholesterol will therefore be classic markers in the monitoring of aging.

Free radicals can damage our DNA by oxidizing nucleic bases. These reactions leave traces: a fragment of oxidized base called 8-hydroxy-2-deoxy-guanosine (8-OHdG).

Biomarkers called « physical criteria

You don’t wake up one morning with gray hair and a cane. Old age is a long process of biological changes.

– The senses

The loss of autonomy generally occurs after the age of 70. It is explained by cognitive, physiological, muscular and articular changes, the first symptoms of which appear between the ages of 40 and 50.

The first sign is presbyopia. At an average age of 44, vision is affected by a loss of accommodation between distance and near vision. Around the age of 60, it is hearing that is affected: presbycusis. 34% of people over 60 have difficulty hearing. The three other senses are then affected: touch, taste and smell.

– The physical and the mental

With old age, the structure of the brain and nervous system changes. With age, these cognitive changes lead to psychomotor slowing down, an alteration of attention or of short-term memory.

The decrease in physical capacities (gripping strength, speed of movement, etc.) are simple and fairly reliable indicators of aging.

Old age brings about other physiological changes such as weight gain, changes in the hair system (gray hair and baldness), drying and degradation of the skin (wrinkles), a decrease in immune resistance or even the loss of teeth. Even the percentage of water in our body decreases.

Is it useful to improve the indicators?

Many therapies aim to improve certain biomarkers. For example, gene therapies for telomerase or hormone cocktails to compensate for age-related decreases.

However, it is not necessarily established that the indicators of aging are also influencers. In some cases, it is very likely that they are mainly an effect (e.g. gray hair). In many other cases, therapies aimed at influencing the indicator should have therapeutic effects. If an indicator changes favorably, the impact will be to some extent favorable to healthy longevity.

We have more and more information about biomarkers and how our actions, therapies etc. influence them. New experiments are not always needed to understand them better. We can use the immense resources of health measures already available through retrospective studies and through the monitoring of ongoing therapies. The more rigorously we use them, the easier it will be to assess and to achieve progress towards longevity.

Many good news this month.

Aubrey de Grey, the iconic leader of SENS, the most renowned and probably the most effective organization in the fight against aging, has announced the receipt of donations totaling approximately $20 million, several times the organization’s annual budget.

Laurent Simons, a gifted Belgian who recently graduated from university at the age of 11, has one ultimate goal: to enable the « immortality » of his grandparents, among others. And that’s why he studies! 

Vitalik Buterin, developer of the Ethereum crypto-currency and a young, gifted billionaire, publicly announces his passion and investments in longevity.

The BioViva organization, presented by Elisabeth Parrish, announces a gene therapy experiment giving excellent results for longevity in mice.

The United Kingdom announces in an official document entitled « Life Science Vision« : <<[…] there is now a wealth of literature on potential pathways and targets that could be used to address the most inevitable cause of disease in human populations.>> (translation) »

The United States clarifies Joe Biden’s stated goal of developing an agency that will address diseases in innovative ways. The name of this future organization is ARPA-H (Advanced Research Projects Agency for Health).

For more information:

The death of death N°147. June 2021. Longevity records of living organisms

Scientist Shin Kubota expresses his vision in the New York Times: « Turritopsis application for human beings is the most wonderful dream of mankind,” he told me the first time I called him. “Once we determine how the jellyfish rejuvenates itself, we should achieve very great things. My opinion is that we will evolve and become immortal ourselves.”. » (November 28, 2012)


Theme of the month : Longevity records of living organisms


Tortue des Galapagos

How to understand the longest lifespan? And why? 

The maximum lifespan of living things is extremely variable depending on the species. Overall, for animals, the maximum lifespan is longer with one or more of the following favorable factors:

  • Predators are rare 
  • The metabolism is slow 
  • Size is large

The differences in lifespan can be enormous between species that are biologically quite close. This is one of the reasons to consider gene therapy or other medical treatment to dramatically increase the maximum lifespan of humans.

This letter includes known cases of extreme longevity. Obviously, in these cases of very long lifespans, only indirect and sometimes questionable measures are possible.

The naked mole rat and the bat, exceptional longevity and no cancer! (35-40 years)

The longevity of naked mole rats is especially surprising when compared to other captive rodents of similar size. Naked mole rats are not expected to live more than six years. However, the oldest naked mole rat known in the laboratory is… 35 years old! And, among some of its fellow rats that are over 30 years old, some females are still fertile.

Researchers have discovered why naked mole rats are cancer-free. It is thanks to hyaluronic acid, a molecule that is thought to prevent the formation of tumors in the body. According to researchers Vera Gorbunova and Andrei Seluanov, who published their results in the journal Nature, the molecular weight of hyaluronic acid in the naked mole rat is five times greater than in mice.

The tiny Brand’s bat, at seven grams, lives for almost forty years. It is the same for the great mouse (Myotis myotis), which is five times heavier. An international team undertook a longitudinal study over eight years. Their results, published in the journal Nature Ecology & Evolution, open up promising avenues for research on aging.

Longest-lived insect: the termite queen (50 years)

Insects are normally thought of as living less than a year as adults. However, termite queens, protected from predators, can reach 50 years.

Birds: The albatross can live up to 80 years

Albatrosses are the largest seabirds in the world: the howler albatross reaches a wingspan of 3.50 meters! Their longevity is also remarkable, as they can live up to 80 years. Wisdom, a 70 years old albatross has laid eggs again. A parrot (cockatoo) has also reached a similar age (82 years).

Oldest amphibian: the cave salamander (100 years)

Naturalists attribute the longevity of the blind salamander Proteus anguinus to its unusually slow metabolism. Tthis salamander takes 15 years to mature, mates and lays eggs only about every 12 years, and barely moves except when foraging for food. In addition, the damp caves of southern Europe where it lives are virtually free of predators, allowing P. anguinus to live beyond 100 years in the wild.

Reptiles: The famous Galapagos tortoises

In 2012, « Lonesome George » died at over 100 years old. Six years after his passing, the centenarian has made a comeback thanks to the revelations of Yale researchers studying his genome! George was the last representative of a species endemic to a Galapagos island. He always shunned any mating in captivity. The scientists who had sequenced his genome during his lifetime as well as that of another species of giant tortoise, revealed the results in the journal Nature.

The biologists detailed 891 genes in these turtles, involved in the function of the immune system. They show that these animals have developed extra copies of genes that allow them to better respond to oxidative stress, known to be a major factor in aging. They also discovered a gene that allows cells to better defend themselves against foreign cells, as well as tumor suppressor genes that are more numerous than in most vertebrates, and others that are involved in DNA repair.

The study of aging in animals is a source of knowledge for humans. Researchers have found some similarities between the genomes of turtles and centenarians.

Jeanne Calment with her 122 years is the person who lived the longest in the history of humanity…, but certainly not enough to impress an old turtle. The longest living turtle seems to have reached 189 years of age.

Sphenodons are other reptiles that can live past a century.

Fish: 150 years for the orange roughy (Hoplostethus atlanticus)

Hoplostethus atlanticus is called « watchfish ». The animal lives in the world’s oceans at depths between 900 and 1,800 meters, especially in submarine canyons.

The species only reaches sexual maturity between 20 and 30 years of age, which could be explained by a low predation rate and the scarcity of prey in the abysses. Adults can measure 75 cm long and weigh 7 kg and the age of the oldest known specimen, determined by radiometric radiation of the mineral accumulations in its internal ears, is said to  be 149 years.

Echinoderms: 200 years for the giant red sea urchin (Astropyga radiata)

Quite common in the Indian Ocean and in part of the Pacific Ocean, this echinoderm owes its name to its color and its size, which can reach nearly 20 cm in diameter, the largest known among sea urchin species. Some individuals have reached the age of 200 years.

Mammals: 200 years for the bowhead whale (Balaena mysticetus)

Living in Arctic waters, the bowhead whale is a cetacean measuring up to 20 meters and weighing around 100 tons. Its longevity has been estimated at more than 200 years thanks to scars left by old wounds caused by whale hunters. This exceptional longevity could be explained by certain genes. For example, analysis of the whale genome shows unique mutations in the ERCC1 gene involved in the repair of damaged DNA. Another gene, called PCNA and associated with cell growth and DNA repair, contains a duplicate section of DNA. This duplication could slow down cetacean aging.

Sharks: 400 years for the Greenland shark (Somniosus microcephalus)

This rather plump grey shark, measuring five meters, lives in the waters of the Arctic Ocean and is the champion of longevity among vertebrates. Its growth is estimated at about 1 cm per year.

In an article published in Science, an international team of researchers describes how they managed to measure the age of 28 Greenland sharks. The results revealed that the largest shark, a female over five meters long, was 392 years old, although there is a significant margin of error of plus or minus 120 years. The sexual maturity of females is thought to be reached at the age of about 150 years.

According to this research by Julius Nielsen at the University of Copenhagen, published in August 2016, the Greenland shark would therefore be the longest-living vertebrate.

Oldest Mollusc: The Ocean Quahog (500 years)

Scientists have determined that the ocean quahog, Arctica islandica , can literally survive for centuries, as demonstrated by one individual, Ming, which has surpassed the 500-year mark (you can determine a mollusk’s age by counting the growth rings in its shell).

Trees. The Giant Sequoia: over 3000 years old!

Some trees seem to have no senescence mechanism. They remain as fertile at the age of several centuries as in their youth.

The Giant Sequoia is characterized by its longevity since it can reach more than 3000 years. 

Many other species of trees can live for centuries: olive trees, oaks. The absolute record seems to be held by a 5,000 year old Bristlecone pine.

Finally, trees, like other plants, can multiply clonally and form a collective organism. In this sense, the clonal colony of aspen Pando is, at 80,000 years, one of the oldest organisms on the planet.

Microscopic organisms: endoliths (10,000 years)

Determining the lifespan of a microscopic organism is a tricky question: in a sense, all bacteria are immortal, as they propagate their genetic information by constantly dividing (rather than having sex and dying of age).

The term « endoliths » refers to bacteria, fungi, amoebas, or algae that live deep underground in cracks in rocks. 

Studies have shown that individuals in some of these colonies undergo cell division only once every hundred years and can have a lifespan of about 10,000 years. 

Technically, this differs from the ability of some microorganisms to recover from stasis or freezing after tens of thousands of years; in a significant sense. Endoliths are continuously « alive », though not very active. Perhaps most importantly, endoliths are autotrophic, meaning that they fuel their metabolism not with oxygen or sunlight, but with inorganic chemicals, which are virtually inexhaustible in their underground habitats.

Biological immortality in lobsters, hydras, sponges and corals

A small number of multicellular animals seem to have no mechanism of senescence. They do not degrade as they age. For example, their fertility remains constant or even increases.

Hydras, like all cnidarians, can regenerate, which allows them to recover from an injury and reproduce asexually. All hydra cells divide continuously. It has been suggested that hydras do not undergo senescence and, as such, are biologically immortal. In a four-year study, three cohorts of hydras showed no increase in mortality with age.

One species of sponge can live up to 11,000 years, namely Monorhaphis chuni, according to a U.S. study published in the journal Aging Research Reviews in 2014.

Some colonial animals, such as corals, can live more than 4,000 years.

Research suggests that lobsters may not slow down, weaken or lose fertility with age, and that older lobsters may be more fertile than younger lobsters. This does not, however, make them immortal in the sense of no impact of senescence, as they are much more likely to die in a shell molt with advancing age due to their increasing size. 

Their longevity may be due to telomerase, an enzyme that repairs long repetitive sections of DNA sequences at the ends of chromosomes, called telomeres. Unlike vertebrates, lobsters express telomerase in adulthood throughout most tissues, which has been suggested to be related to their longevity.

It has been claimed that some fish, notably the bigmouth buffalo, do not have measurable senescence. However, with the exception of the Greenland shark, no captured fish whose age was measured exceeded 200 years.

Why no biological immortality in vertebrates, even those without predators?

Natural selection, at least for vertebrates, always results in species with limited lifespans. This can be explained by the fact that an animal species without aging would lose its genetic diversity and be eliminated by any environmental change. This also explains sexual reproduction: more genetic mixing means more adaptability to the environment. 

But in a certain sense, systematic aging remains an evolutionary mystery. Indeed, even salamanders or cave fish in an extremely stable environment (hundreds of thousands of years) and without predators do not seem to live much beyond a century.

Cnidaria: biological immortality and rejuvenation for the jellyfish Turritopsis nutricula

Small in size, but long in life expectancy. The jellyfish Turritopsis nutricula measures only 5 mm in diameter, but could live ad vitam æternam. Native to the Caribbean Sea, the species is nowadays very widespread. Several specialists are worried about its proliferation over the whole globe.

Thanks to a particular cellular process called transdifferentiation, the animal is able to stop its aging and even to become younger. It is already known that the best way to push a Turritopsis Nutricula to regenerate is to stress it. For example, in case of an injury, the process starts immediately and within a few days, the jellyfish returns to its juvenile stage and starts a new life.

This makes it an exceptional subject of study for biologists and geneticists, and a subject of interest for some pharmaceutical groups who are already considering the production of a rejuvenating cream containing Turritopsis DNA. « It’s as if a butterfly were able to go back to the caterpillar stage, » says Stefano Piraino, a professor at the University of Salento in Italy.

Dormancy as a longevity strategy

Dormancy is a term that covers all forms of slowed life. 

It is the period in the life cycle of an organism when growth, development and/or physical activity (in animals) are temporarily stopped. This reduces metabolic activity and thus helps the organism to conserve energy.

Especially in extreme environments, or ones of a very seasonal nature, dormancy can only be an adaptive strategy if a stimulus for the seed to move from a « dormant » to a « non-dormant » state is made possible at the « right time ». And indeed, dormancy often does indeed cease when environmental conditions permit.

The longevity of a seed (the length of time it can remain in a dormant state without losing its ability to germinate) is highly variable. In plants, all the intermediaries exist, between the seed of the lotus which holds the record of longevity (about1000 years) and the seeds of cocoa tree, little dehydrated, which must, under pain of death, find, in the few days following their maturation, conditions allowing their germination. Scientists have even managed to germinate seeds of silence (a plant with white flowers) frozen for nearly 32,000 years in the Siberian subsoil! 

Although costly, the dormancy strategy prevents all individuals carrying the same genotype from simultaneously encountering an environment not conducive to their survival or reproduction.

A rotifer survived 24,000 years of freezing in the Arctic permafrost.

Bdelloid rotifers generally live in aquatic environments and have an incredible ability to survive. Russian scientists discovered these creatures in a core of frozen soil extracted from the Siberian permafrost using a drill.

In a study published recently in the journal Current Biology, the Russian researchers used radiocarbon dating to determine that the creatures they recovered from the permafrost (ground that is frozen year-round, except for a thin layer near the surface) were about 24,000 years old.

This is not the first time ancient life has been « revived » from a permanently frozen habitat.

Antarctic moss stems were successfully regenerated from a 1,000-year-old sample and a living campion flower was regenerated from seed tissue, probably stored by an Arctic squirrel, that had been preserved in 32,000-year-old permafrost. Simple worms, called nematodes, were « resurrected » from permafrost at two locations in northeastern Siberia in sediments more than 30,000 years old.


This month’s good news: Private investments for longevity. The European Union announces widespread health data sharing for its citizens by 2025.


  • Vitalik Buterin donates over $2 million to the Methuselah Foundation.
  • Michael Greve, founder of Forever Healthy, pledges 300 million to advance rejuvenation startups.
  • In an unfortunately poorly circulated document, the European Commission announces that it aims to have EU citizens able to share their health data with the healthcare providers and authorities of their choice by 2025. This would mean, if followed through, that European citizens will be able to easily share their data for scientific research, including healthy longevity.

For more information:

VIRTUAL CONFERENCE On Big Data, A.I. and Healthy Longevity. How to progress faster and better for all scientists ? Thursday, September 9, 2021

Joint Heales and International Longevity Alliance for a Virtual Conference on Thursday, September 9, from 5:00 PM to 10:00 PM CET (from 8:00 AM to 1:00 PM PDT) , titled :

Big Data, A.I. and Healthy Longevity.

How to progress faster and better?

Our goal is to contribute to creating a system that is trusted by citizens, managed by a public institution (or an NGO), where, by default (opt-out), all health data (anonymised or pseudonymised) can be used for scientific research (and not for other use). The ultimate goal is to enable everyone to live a longer and healthier life.

Here is a communication from the Commission to the European Parliament: « Those actions will be funded through the EU4Health programme200, DEP and Horizon Europe programmes with the goal by 2025 to ensure that : citizens from all the Member States are able to share their health data with healthcare providers and authorities of their choice. »

Register for the conference to receive the zoom link

PROGRAM

(This program is subject to change)

5:00 pm – 5:20 pm : Introduction by Didier Coeurnelle, Ilia Stambler, Sven Bulterijs and Marion Steenacker, scientific consultant at Heales

5:20 pm – 05:40 pm : Giovanni Briganti, AI4 Belgium : « Artificial Intelligence for health in Belgium. »

Abstract : “Artificial Intelligence shows many promises as well as challenges in the domain of Health. In this talk Giovanni Briganti will outline the main domains of health AI and how its implementation is being tackled in Belgium through the Health vertical of the AI4Belgium national coalition. »

Bio : “Giovanni Briganti, MD, PhD is a physician-scientist at CHU Brugmann, Brussels. He leads the Health vertical of AI4Belgium, the Belgian national coalition for AI. He researches Bayesian Artificial Intelligence, specifically the application of Bayesian Networks and other graphical models for the study of mental disorders. « 


05:40 pm- 6:00 pm : Ben Goertzel, CEO and founder of SingularityNET : « Decentralized AI for Healthy Longevity. »

Abstract : « Modern AI tools possess unprecedented potential for uncovering the root causes of human aging and age-associated disease.   However, AI needs data to do its work, and the larger and more diverse the datasets, the better.   Today the vast bulk of data that would be useful to feed AI algorithms oriented to study human longevity is locked up in proprietary corporate or government databases.   To solve aging effectively likely requires a multipronged effort: Use of decentralized blockchain based networks and other similar tools to incentivize individuals to share their data with researchers, and use of advanced (e.g. neural-symbolic) AI tools to draw inferences regarding longevity from the messy and diverse datasets that can realistically be assembled.   Work in this direction within the SingularityNET, OpenCog and Rejuve projects will be briefly described, as an example of this approach, involving joint AI analysis of datasets derived from long-lived humans, long-lived model organisms, and individuals of various ages and various levels of health. »

Bio : « Ben Goertzel is an artificial intelligence researcher, and CEO and founder of SingularityNET. He is the CEO and founder of SingularityNET, a project combining artificial intelligence and blockchain to democratize access to artificial intelligence.  He was a Director of Research of the Machine Intelligence Research Institute. He is also chief scientist and chairman of AI software company Novamente LLC; chairman of the OpenCog Foundation; and advisor to Singularity University. Ben Goertzel was the Chief Scientist of Hanson Robotics, the company that created Sophia the Robot. »


6:00 pm – 6:20 pm : Carina Dantas, The Digital Health Society / SHINE 2Europe : « What do citizens want when they share their data? »,  

Bio : « Carina Dantas has over 20 years-experience in health and social care. She is CEO of SHINE 2Europe, Senior International Project Manager for the ECHAlliance, Management team member of The Digital Health Society, member of the Standing Committee on Policy and Advocacy of the International Health Literacy Association, the Advisory Board of the H2020 projects ReHyb, VisuAAL, Tactile, Homes4life and reviewer of ICF Journal, Geriatrics and MDPI. »


6:20 pm – 6:40 pm : Thierry Geerts, Country Director Google Belgium and Luxembourg : « Homo Digitalis : How digitalization makes us more human”. « .

Abstract : « Digital applications simplify our lives, save time during the day, find information, stay healthy but especially can help us stay in contact with loved ones despite the pandemic or if they live thousands of km from here. In short, all things that are fundamentally… human! The changes that we are experiencing with digitalization are particularly significant, on a technical, human and social level. This digitalization does not make us less but more human, as a result of which, people themselves have evolved into what you could call a new human species: homo digitalis. Homo sapiens feared a mammoth, then a train or electricity. Today we are afraid of digitalization, AI or messages on social media. But technology itself is neutral, we don’t have to fear it. What we need to do is what we’ve done with technology in the past: overcome fears and embrace innovation. We have to take control of technology: learn about it and experiment with it. It will have a huge impact on healthcare. AI will improve diagnosis, therapies. Connected devices will help us to stay healthy. If we invest in those technologies, we can live longer and healthier and reduce the cost of healthcare for society. This new human being enriches her or his life thanks to digital applications, has the opportunity to spend more time on things that really matter in their lives like personal development, health, family and has instant contact with 4 billion other people”

Bio : « Since 2011, Thierry Geerts has been heading Google in Belgium and Luxembourg, the company that has become much more than just a search engine. He graduated from the VUB as a Solvay Business Engineer and soon became general manager of an industrial laundry company. With the advent of the internet in the mid-1990s, he reoriented himself towards the media industry and held various management positions at VUM (now Mediahuis), publisher of newspapers such as De Standaard and Het Nieuwsblad. His book Digitalis (2018), in which he describes the possibilities of the digital world, has meanwhile sold more than 25,000 copies. In 2021 he published his new book, Homo Digitalis, about the impact of the digital revolution on people and society. »


6:40 pm – 7:00 pm : Y-H Taguchi :  » The Big Data Situation in Japan (and other Asian countries) »

Abstract: « In Asian countries, Big Data usage in health care is rapidly developing. In this talk, I will talk about situations in these countries, especially focusing on Japan, China and Korea. Recent corna pandemic accelerated the progress of usage of big data in health care, although Japan is so behind the other two countries.   Big Data usage in health care will be increasingly important on Asian countries including these three countries. »

Bio : « Prof. Taguchi is currently a Professor at Department of Physics, Chuo University. Prof. Taguchi received a master degree in Statistical Physics from Tokyo Institute of Technology, Japan in 1986, and PhD degree in Non-linear Physics from Tokyo Institute of Technology, Tokyo, Japan in 1988. He worked at Tokyo Institute of Technology and Chuo University. He has been with Chuo University (Tokyo, Japan) since 1997. He currently holds the Professor position at this university. His main research interests are in the area of Bioinformatics, especially, multi-omics data analysis using linear algebra. Dr. Taguchi has published a book on bioinformatics, more than 100 journal papers, book chapters and papers in conference proceedings. »


7:00 pm – 7:20 pm : Break


7:20 pm – 7:40 pm : Agbolade Omowole, Founder of Longevity Nigeria : « Application of A.I. and Big Data on Healthy Longevity in Africa and Data Ethics Oversight. »

Abstract : « In the past, Nigerians have been overly dependent on health care solutions from the developed world until recently. Today lots of startups are disrupting the healthcare industry in Nigeria and providing world class solutions to Nigerians and Africans. I will present information about how a number of organizations in Nigeria are leveraging A.I. and Big Data to improve the lives of Nigerians and why they should have an ethical oversight. The ethics oversight will highlight the basic principles of data ethics that should be incorporated into big data and artificial intelligence. »

Bio : « Agbolade Omowole is a passionate researcher on the ethics of AI and data driven technologies. He is the founder of Longevity Nigeria, a healthy longevity activism organization that is creating awareness on improving healthspan in Nigeria, and Africa at large. »


7:40 pm – 8:00 pm : Karen Sandler : « Digital Autonomy and Longevity ».

Bio : “Karen M. Sandler is the executive director of the Software Freedom Conservancy, a charitable nonprofit dedicated to empowering people to control their technology with software freedom. She is known as a cyborg lawyer for her advocacy for software as a life-or-death issue, particularly in relation to the software on medical devices. Prior to joining Conservancy, she was the executive director of the GNOME Foundation. Before that, she was the general counsel of the Software Freedom Law Center. Karen co-organizes Outreachy, the award-winning outreach program for people who face under-representation, systemic bias, or discrimination in tech . Karen is an adjunct Lecturer-In-Law at Columbia Law School. She is the recipient of the Free Software Foundation’s 2017 Award for the Advancement of Free Software as well as an O’Reilly Open Source Award.”


8:00 pm – 8:20 pm : Didier Coeurnelle, co-chair at Heales : « General introduction to Legislation and Organisations concerning the public sharing of Health Data around the world. »

Bio : “Didier Coeurnelle Didier Coeurnelle (Belgium) is co-chair of Heales (Healthy Life Extension Society), which publishes a monthly newsletter of information: The Death of Death and organizes international conferences. He is a spokesman of the French association Technoprog, which aims to “spread the themes and questions related to technologies that could extend and enhance the lives of individuals and of humankind”. He is also a member of the board of the International Longevity Alliance, an active member of the social and environmental movement and a jurist.


8:20 pm – 8:40 pm : Stefan Sorgner : « A philosopher’s point of view. Why is it important to share more for the collective? »

Abstract : « To guarantee that an enormous plurality of different lifestyles can be embraced in a society while a highly efficient universal healthcare system is available, we need a democratic usage of our digital data. I will sketch central reflections concerning a promising initial step for developing appropriate social, legal and political structures for realizing a proper democratic usage of our digital data. »

Bio : « Stefan Lorenz Sorgner is a philosophy professor at John Cabot University in Rome and is director and co-founder of the Beyond Humanism Network, Fellow at the Institute for Ethics and Emerging Technologies (IEET), Research Fellow at the Ewha Institute for the Humanities at Ewha Womans University in Seoul and Visiting Fellow at the Ethics Centre of the Friedrich-Schiller-University in Jena. He is editor of more than 10 essay collections, and author of the following monographs: Metaphysics without Truth (Marquette University Press 2007), Menschenwürde nach Nietzsche (WBG 2010), Transhumanismus (Herder 2016), Schöner neuer Mensch (Nicolai, 2018), Übermensch (Schwabe 2019), On Transhumanism (Penn State University Press); We have always been cyborgs (Bristol University Press 2022). In addition, he is Editor-in-Chief and Founding Editor of the “Journal of Posthuman Studies” (a double-blind peer review journal, published by Penn State University Press since 2017). Furthermore, he is in great demand as a speaker in all parts of the world (World Humanities Forum, Global Solutions Taipei Workshop, Biennale Arte Venezia, TEDx) and a regular contact person of national and international journalists and media representatives (Die Zeit, Cicero, Der Standard; Die Presse am Sonntag, Philosophy Now). www.sorgner.de & www.mousike.de« 


8:40 pm – 9:00 pm : Break

9:00 pm – 9:45 pm : Debate and proposals: « How to progress faster and better for all scientists? » Participants : Karen Sandler, Thierry Geerts, Stefan Sorgner, Ben Goertzel and Didier Coeurnelle.

9.45 pm -10:00 pm : Official closing by Ilia Stambler and Didier Coeurnelle

The death of death N° 146. May 2021. Regeneration

Thomas Pesquet, the current star of French scientific research: « If we could unlock the key to aging and figure out how to reverse it, that would be super convenient. » (translation)


Theme of the month: Regeneration


All living beings are capable, at different levels, of repairing damage to their organism. 

In biology, regeneration is the capacity of living organisms to rebuild themselves after a natural or accidental destruction of a part of themselves. 

Stem cells: the key to regeneration?

Regeneration can involve cells, organs or functional parts of certain living beings. The ability to regenerate is mainly carried by cells of the body that will reprogram themselves to replace the damaged tissue or organ. Some of these cells called « stem cells » are generated either by the bone marrow and can circulate in the body, or by the tissues themselves.

 Regeneration in humans

The human body is constantly subject to cell death and regeneration. However, this regeneration is not exactly the same depending on the type of organs and cells.

Some cells are completely replaced by new ones in a very short time. For example, the cells of the intestines and stomach are only used for a few days before being evacuated by the body. The skin is completely renewed in a few weeks due to external aggressions. Some cells even live only a few hours, like white blood cells.

On the other hand, some cells are renewed slowly. For example, it takes about ten years for bones to be completely regenerated. Heart muscles regenerate by only 1% each year after the age of 20.

But our body also contains cells that never regenerate! This is the case of oocytes or certain neurons in the cerebral cortex.

We must not confuse regeneration and healing, even if they can be observed together, they are two very distinct phenomena. Healing is only a partial repair of the cells, but does not allow an identical reproduction.

We certainly cannot regrow a leg or an arm, but some animals can regenerate whole parts of their body!

Regeneration in living beings

The regeneration capacities of certain plants, notably trees, are remarkable. But the genetic and physiological functioning is so different from that of animals, and therefore also from that of humans, that there is no prospect of application against human senescence appearing conceivable in the short or medium term.

The ascidian, a curious small marine invertebrate in the shape of a wineskin, has the ability to renew its tissues very quickly after serious injuries. Other invertebrates, such as the flatworm and the planarian, can regenerate their head from a tail fragment and vice versa. These invertebrates are not the only animals with such regenerative powers.

Among vertebrates, too, we can find experts in regeneration. The axolotl, a small amphibian that can regrow its limbs, organs and even parts of its brain. The zebrafish regenerates its heart tissue without needing stem cells. Salamanders regenerate their limbs, heart, tail, eyes, kidneys, brain and spinal cord throughout their lives. 

How do these animals with regenerative abilities manage to regrow such complex structures?

Understanding the regeneration process

After an amputation, stem cells accumulate at the site of injury in a structure called the blastema. A major part of current research focuses on how signals from the injury site indicate to stem cells to form the blastema and begin dividing to rebuild the missing structure. 

But what happens at the level of the stem cells themselves? Do the animals use a single type of blastema stem cell that can differentiate into multiple tissues? Or do different groups of stem cells produce the different tissues required to form the new organ?

Recent research in animals with regenerative abilities has shown that stem cells use a variety of strategies to reconstitute missing body parts from multiple tissues, such as muscle, nerve and skin. 

In this 2014 study, scientists combed through the 23,000 genes of Anolis carolinensis, a lizard about 20 centimeters long. Its complete genetic sequencing had already been completed in 2011. But this time, the study’s researchers scanned all the genes during tail regeneration to isolate those responsible. The result: at least 326 genes are activated in the phenomenon, a real « recipe » in the lizard’s DNA.

Another group of scientific researchers in the United States recently solved the mystery of planarian worm regeneration. They discovered that adult individuals have pluripotent stem cells that can make all types of cells in the animal’s body. 

In addition to stem cells, the regeneration process uses differentiated cells that have stopped dividing and « start » to multiply again to replace lost tissue. This phenomenon is present in zebrafish where a heart muscle cell divides to reconstitute the missing tissue. This regenerative process has also been demonstrated in the heart of young mice, but it quickly disappears as the animal grows.

Future Research and Challenges: Enabling human rejuvenation through regeneration

As adults, humans can regenerate certain organs such as the liver or skin. Unfortunately, many other human tissues do not have this ability. One of the goals of regenerative medicine is to find ways to stimulate tissue regeneration or make replacement tissues. One day, this could be one of the ways to « cure » humans of aging.

In December 2018, the scientist Michael Levin from Tufts University, demonstrated that by changing the electrical pattern between cells in the planarian worm this resulted in activation of cells indicating to the body its shape by guiding regeneration.

How to limit growth to what is useful (avoid cancerous growths)? How to « start », « reactivate » these mechanisms to allow the regeneration of organs that arenot destroyed, but senescent? This research requires a better understanding of the genetic and molecular mechanisms of regeneration. 

Progress in the use of stem cells, gene therapy, and the knowledge of genetic mechanisms linked to regeneration open up considerable perspectives. This could well be one of the avenues studied by the USA in the framework of the initiative announced below.


Good News of the Month: U.S. President Joe Biden Announces Advanced Health Care Agency in First Address to U.S. Congress


« The Department of Defense has an agency called DARPA (Defense Advanced Research Projects Agency), whose mission is to develop advances to strengthen our national security. This agency gave birth to the Internet, GPS and many other things. The National Institutes of Health, NIH, should create a similar agency for advanced research projects in the health field. To develop breakthroughs – to prevent, detect and treat diseases like Alzheimer’s, diabetes and cancer.

This is a personal issue for many of us. I can’t think of a more worthy investment. And I don’t know of anything more bipartisan. Let’s end cancer as we know it. It’s within our power. » (Source)

The DARPA agency specializes in « disruptive » technologies. So this new agency could quickly target « disruptive » research in health and anti-aging.


For more information: